 Connection
Lavanya Kondapalli to Humans
This is a "connection" page, showing publications Lavanya Kondapalli has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.245 |
|
|
|
-
Quintana RA, Ghosh AK, Kondapalli L. Mind the Gap: Differences in Acute Myocardial Infarction Care Due to a Cancer Diagnosis in England. Circ Cardiovasc Qual Outcomes. 2023 06; 16(6):e010080.
Score: 0.024
-
Lenneman C, Harrison D, Davis SL, Kondapalli L. Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities. Curr Treat Options Oncol. 2022 12; 23(12):1793-1803.
Score: 0.023
-
Kondapalli L, Arora G, Hawi R, Andrikopoulou E, Estes C, Patel N, Lenneman CG. Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic. Curr Treat Options Oncol. 2022 09; 23(9):1288-1302.
Score: 0.023
-
Kondapalli L, Neilan TG. Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology. Eur Heart J. 2021 12 21; 42(48):4978-4980.
Score: 0.022
-
Kondapalli L, Medina T, Groves DW. Practical cardiovascular imaging approach to diagnose immune checkpoint inhibitor myocarditis. Eur Heart J Cardiovasc Imaging. 2021 03 22; 22(4):372-374.
Score: 0.021
-
Kondapalli L, Bottinor W, Lenneman C. By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis? Circulation. 2020 12 15; 142(24):2312-2315.
Score: 0.020
-
Kondapalli L, Moslehi J, Bonaca MP. Inflammation begets inflammation: cancer and acute MI. Eur Heart J. 2020 06 14; 41(23):2194-2196.
Score: 0.020
-
Kondapalli L, Worth S, Hawi R, Vachhani P, Arora G, Bhatia R, Lenneman CG. Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors. Vasc Med. 2020 06; 25(3):246-254.
Score: 0.019
-
Kondapalli LA, Molinaro TA, Sammel MD, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod. 2012 Sep; 27(9):2690-7.
Score: 0.011
-
Kondapalli L, Soltani K, Lacouture ME. The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies. J Am Acad Dermatol. 2005 Aug; 53(2):291-302.
Score: 0.007
-
Roy S, Lakritz S, Schreiber AR, Kuna EM, Bradley CJ, Kondapalli L, Diamond JR. Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane + anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study. Eur J Cancer. 2024 Jan; 196:113426.
Score: 0.006
-
Patel M, Hudson O, Han J, Kondapalli L, Arora G, Hawi R, Andrikopoulou E, Estes C, Johnson AM, Lenneman C. Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond. Curr Treat Options Oncol. 2023 11; 24(11):1489-1503.
Score: 0.006
-
Roy S, Lakritz S, Schreiber AR, Molina E, Kabos P, Wood M, Elias A, Kondapalli L, Bradley CJ, Diamond JR. Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study. Eur J Cancer. 2023 05; 185:69-82.
Score: 0.006
-
Zaha VG, Hayek SS, Alexander KM, Beckie TM, Hundley WG, Kondapalli L, Ky B, Leger KJ, Meijers WC, Moslehi JJ, Shah SH. Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association. Circulation. 2021 12 21; 144(25):e551-e563.
Score: 0.005
-
Schreiber AR, Kagihara J, Eguchi M, Kabos P, Fisher CM, Meyer E, Molina E, Kondapalli L, Bradley CJ, Diamond JR. Evaluating anthracycline?+?taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study. Breast Cancer Res Treat. 2022 Jan; 191(2):389-399.
Score: 0.005
-
Alvarez-Cardona JA, Ray J, Carver J, Zaha V, Cheng R, Yang E, Mitchell JD, Stockerl-Goldstein K, Kondapalli L, Dent S, Arnold A, Brown SA, Leja M, Barac A, Lenihan DJ, Herrmann J. Cardio-Oncology Education and Training: JACC Council Perspectives. J Am Coll Cardiol. 2020 11 10; 76(19):2267-2281.
Score: 0.005
-
Graffagnino J, Kondapalli L, Arora G, Hawi R, Lenneman CG. Strategies to Prevent Cardiotoxicity. Curr Treat Options Oncol. 2020 04 08; 21(4):32.
Score: 0.005
-
Dent SF, Kikuchi R, Kondapalli L, Ismail-Khan R, Brezden-Masley C, Barac A, Fradley M. Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-15.
Score: 0.005
-
Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Pi?a IL, Volgman AS. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation. 2018 02 20; 137(8):e30-e66.
Score: 0.004
-
Mountantonakis SE, Elkassabany N, Kondapalli L, Marchlinski FE, Mandel JE, Hutchinson MD. Provocation of atrial fibrillation triggers during ablation: does the use of general anesthesia affect inducibility? J Cardiovasc Electrophysiol. 2015 Jan; 26(1):16-20.
Score: 0.003
-
Gazta?aga L, Frankel DS, Kohari M, Kondapalli L, Zado ES, Marchlinski FE. Time to recurrence of atrial fibrillation influences outcome following catheter ablation. Heart Rhythm. 2013 Jan; 10(1):2-9.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|